Alcohol use was the most common predictor of escalating cannabis vaping among youth and young adults, independent of demographic factors, according to research by UTHealth Houston published this month in the journal Social Science & Medicine.
Opinion piece on using opioid crisis as a blueprint for addressing Xylazine and F2 spread
A new study published in the Journal of Addiction Medicine conducted by a team of Stony Brook University researchers used the PROMOTE Prenatal Screener 鈥� a unique screening tool for use during pregnancy 鈥� to pinpoint vulnerabilities for substance use.
Racial Differences in Opioid Use Disorder
University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.
Pennsylvania legislators and top medical experts will come together to address the growing xylazine crisis at an upcoming free symposium. The event, titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis," will be held on November 23, 2024, at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
Newly-published NCCN Guidelines for Patients: Quitting Smoking explains what the evidence and expert consensus is on how to best use the tools that exist to help anyone quit for good.
Online e-cigarette retailers are not consistently adhering to laws aimed at preventing the sale of vaping products to minors, including regulations on age verification, shipping methods and flavor restrictions, report researchers at the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego.
Health System to serve as a lead core enrollment site for diverse, national health database
Hackensack Meridian JFK Johnson Rehabilitation Institute, a nationally recognized leader in physical medicine and rehabilitation, is proud to announce its participation in the upcoming American Academy of Physical Medicine And Rehabilitation Annual Assembly (AAPMR) 2024 Annual Assembly, taking place November 6-10 in San Diego, CA.
UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.
A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.
Researchers from WashU Medicine and Northwestern University developed an implantable device that can detect an overdose and rapidly deliver naloxone.
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
A study that used a specialized type of magnetic resonance imaging (MRI), named neuromelanin-sensitive MRI, showed that this type of MRI signal was increased in regions of the midbrain in young adults ages 20 to 24 who had an extensive alcohol and drug use history. The findings are published early online in the American Journal of Psychiatry.
According to new research from UC San Diego School of Medicine, men and women rely on different biological systems for pain relief, which could help explain why our most powerful pain medications are often less effective in women.
As cannabidiol products 鈥� commonly known as CBD 鈥� become more readily available, West Virginia University researchers are working to gain a broader understanding of how the substance influences driving performance and whether the effects differ between men and women.
In response to聽President Biden's call to reclassify marijuana, the DEA began the process of rescheduling marijuana from a Schedule I to Schedule III drug. ...
The University of Arkansas at Little Rock has received $5 million in federal funding to address the growing drug and opioid crisis among youth in Arkansas. The award comes from appropriations language authored by U.S. Sen. John Boozman passed into law in 2024. The funding is administered by the Office of National Drug Control Policy.
Leading experts from across the world will join forces in the UK this week in a bid to confront the wide-reaching challenges and curb the devastating effects of gambling.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right